Roivant Sciences Ltd. (ROIV)
27.80
0.00 (0.00%)
USD |
NASDAQ |
Mar 19, 16:00
27.81
+0.01
(+0.04%)
After-Hours: 20:00
Roivant Sciences EPS Diluted (Quarterly) : -0.3816 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | -0.0404 |
| Moderna, Inc. | -2.107 |
| GSK Plc | 0.414 |
| Kiniksa Pharmaceuticals International Plc | 0.1741 |
| Silence Therapeutics Plc | -0.0831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -313.70M |
| Revenue (Quarterly) | 1.999M |
| Total Expenses (Quarterly) | 267.89M |
| Enterprise Value | 16.18B |
| Gross Profit Margin (Quarterly) | 30.42% |
| Profit Margin (Quarterly) | -15.69K% |
| Earnings Yield | -4.20% |
| Normalized Earnings Yield | -4.608 |